Novelion Therapeutics is a pharmaceutical company that researches and develops novel drugs for the treatment of inherited retinal diseases.
Business Model:
Revenue: $135.1M
Employees: 51-200
Address: 1800 - 510 West Georgia Street
City: Vancouver
State: british columbia
Zip: V6B 0M3
Country: CA
Novelion Therapeutics is a pharmaceutical company that researches and develops novel drugs for the treatment of inherited retinal diseases.
Contact Phone:
+16175007867
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/9/1999
Ticker Symbol:
NVLN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2015 | Aralez Pharmaceuticals | Post-IPO Equity | 0 |
6/2015 | Aralez Pharmaceuticals | Post-IPO Equity | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Post-IPO Equity | $22M | 8/2021 | Post-IPO Debt | 1 | $50M |
Hercules Capital Hercules Capital |
---|
Announced Date | Name | Price |
---|---|---|
6/2016 | Aegerion Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|